Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS
· Delayed Price · Currency is USD
27.51
0.00 (0.00%)
At close: Mar 10, 2025
Hikma Pharmaceuticals Employees
Hikma Pharmaceuticals had 9,500 employees as of December 31, 2024. The number of employees increased by 400 or 4.40% compared to the previous year.
Employees
9,500
Change (1Y)
400
Growth (1Y)
4.40%
Revenue / Employee
$329,158
Profits / Employee
$37,789
Market Cap
5.79B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
Longduoduo Company | 49 |
Hikma Pharmaceuticals News
- 15 days ago - Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Pre-Recorded (Transcript) - Seeking Alpha
- 16 days ago - Hikma Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg - Benzinga
- 2 months ago - Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg - PRNewsWire
- 7 months ago - Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices - Benzinga
- 7 months ago - Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day - PRNewsWire
- 7 months ago - KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months - Benzinga
- 7 months ago - KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months - PRNewsWire